多囊卵巢综合征中的致病性抗苗勒管激素变异
研究对80例多囊卵巢综合征(PCOS)患者和24例生殖功能正常对照进行全基因组测序,发现AMH基因罕见变异;在643例PCOS患者和153例对照中靶向测序验证,双荧光素酶报告实验显示18个PCOS特异性变异中17个(94%)显著降低AMH信号,对照中6个变异均无显著信号缺陷。
要点
- 在PCOS患者中鉴定出18个特异性罕见AMH变异,其中17个(94%)显著降低AMH信号。
- 对照组中6个AMH变异均未显示显著信号缺陷。
- 研究提示AMH信号降低可能是PCOS发病机制之一。
核心结论
- 据作者所知,本研究首次鉴定出与常见PCOS表型相关的罕见遗传变异。
- 研究结果提示AMH信号降低可能是PCOS的发病机制。
- AMH通过抑制CYP17活性降低雄激素生物合成,因此AMH变异在PCOS中的潜在作用机制可能是AMH介导的CYP17抑制减弱导致雄激素生物合成增加。
研究设计与样本
- 对80例PCOS患者和24例生殖功能正常对照进行无偏全基因组测序(WGS)。
- 对643例PCOS患者和153例对照进行AMH靶向测序以重复WGS发现。
- 采用双荧光素酶报告实验测量变异对下游AMH信号的影响。
主要发现
- 在PCOS患者和对照中共发现24个罕见(次要等位基因频率<0.01)AMH变异,其中18个为PCOS女性特异性。
- 18个PCOS特异性变异中17个(94%)显著降低AMH信号,而对照组中观察到的6个变异均无显著信号缺陷。
- 因此,在部分PCOS患者中鉴定出降低AMH介导信号的罕见AMH编码变异。
关键数值与推荐
- 罕见变异定义为次要等位基因频率<0.01。
- 18个PCOS特异性变异中17个(94%)显著降低AMH信号,对照组6个变异均无显著信号缺陷。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Polycystic ovary syndrome (PCOS), a common endocrine condition, is the leading cause of anovulatory infertility. OBJECTIVE: Given that common disease-susceptibility variants account for only a small percentage of the estimated PCOS heritability, we tested the hypothesis that rare variants contribute to this deficit in heritability. DESIGN, SETTING, AND PARTICIPANTS: Unbiased whole-genome sequencing (WGS) of 80 patients with PCOS and 24 reproductively normal control subjects identified potentially deleterious variants in AMH, the gene encoding anti-Müllerian hormone (AMH). Targeted sequencing of AMH of 643 patients with PCOS and 153 control patients was used to replicate WGS findings. MAIN OUTCOME MEASURES: Dual luciferase reporter assays measured the impact of the variants on downstream AMH signaling. RESULTS: We found 24 rare (minor allele frequency < 0.01) AMH variants in patients with PCOS and control subjects; 18 variants were specific to women with PCOS. Seventeen of 18 (94%) PCOS-specific variants had significantly reduced AMH signaling, whereas none of 6 variants observed in control subjects showed significant defects in signaling. Thus, we identified rare AMH coding variants that reduced AMH-mediated signaling in a subset of patients with PCOS. CONCLUSION: To our knowledge, this study is the first to identify rare genetic variants associated with a common PCOS phenotype. Our findings suggest decreased AMH signaling as a mechanism for the pathogenesis of PCOS. AMH decreases androgen biosynthesis by inhibiting CYP17 activity; a potential mechanism of action for AMH variants in PCOS, therefore, is to increase androgen biosynthesis due to decreased AMH-mediated inhibition of CYP17 activity.
引用
- Gorsic LK, Kosova G, Werstein B, et al. Pathogenic Anti-Müllerian Hormone Variants in Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2017. PMID: 28505284. doi:10.1210/jc.2017-00612
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。